Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 28, 2026 15:24 ET | Source: Steel Power

Steel Power Male Enhancement Claims Evaluated: Complete SteelPower Performance Report for Men

2026 SteelPower performance report covers male enhancement formula details, ingredient research context, pricing, and guarantee disclosures.
March 28, 2026 15:00 ET | Source: MoonLake Immunotherapeutics AG

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

Results from the Phase 3 VELA clinical trials in adults with moderate-to-severe hidradenitis suppurativa (HS) show that clinical responses continue to improve to Week 40, with 62% of patients treated...
March 28, 2026 12:16 ET | Source: SonusZen

SonusZen Claims Evaluated: Testing the Legitimacy of Sonus Zen Formulation for Hearing Support

SonusZen hearing support ingredients, Sonus Zen tinnitus supplement formulation transparency, B vitamin research, auditory health claims for 2026
March 28, 2026 11:00 ET | Source: Sanofi Winthrop Industrie

Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session

AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session Across the COAST 1, COAST 2, and SHORE phase 3 studies, amlitelimab, dosed...
March 28, 2026 04:05 ET | Source: Johnson & Johnson EMEA

New SPRAVATO® (esketamine nasal spray) data support robust effectiveness and show durable effect for treatment resistant depression in a real-world setting

Johnson & Johnson presents findings from the largest European real-world dataset for esketamine nasal spray (NS) which confirm its effectiveness and tolerability in a real-world patient...